Granulocyte colony–stimulating factor treatment of the bone marrow donor decreases prostaglandin E2 production of mesenchymal stem cells
Hepatocyte growth factor increases in the bone marrow plasma after granulocyte colony–stimulating factor priming
Differentiation and surface markers of granulocyte colony–stimulating factor–primed bone marrow derived mesenchymal stem cells are similar to unprimed